In London yesterday the BMA's GPs Committee hosted a conference of representatives from England's Local Medical Committees (LMCs) which backed a motion to increase scrutiny of the controversial data system.Dr Katie Bramall-Stainer, CEO of Cambridgeshire LMC, said recent news reports and comment from the National Data Guardian (NDG) suggested "Palantir have no business being involved" in the £360 million ($435 million) FDP project, for which NHS England is set to start procurement in the coming weeks.The motion backed by the conference, which helps steer policy decisions of the BMA's powerful GPs Committee, calls for the union to work with NHS England to scrutinize organizations submitting tenders to ensure a demonstrable positive track record on security, privacy and ethics.The England LMC conference said the BMA should work with NHS England on four existing secure data platforms supported by the BMA and the Royal College of GPs that could provide "some or all of the requirements" for the FDP.- Watchdog warns UK health data platform could damage patients' trust- UK's National Health Service will roll existing Palantir work into patient data platform- NHS tech chief dismisses concerns over loss of statutory power to protect patient data- UK government set to extract hospital data to Palantir system without patient consentNHS England began discussing the FDP with suppliers in April."